dose

January 29, 2021 | Maryam Shahzad

‘To Every Corner of Every Community’: Hogan Launches Vaccine Confidence Campaign

Maryland Gov. Larry Hogan has launched GoVAX: Maryland’s COVID-19 vaccine confidence campaign. Hogan called the effort an “aggressive, grassroots public outreach campaign” to encourage vaccine confidence and urge residents to get vaccinated when it’s their turn and doses are available. “Over the next several months, we will be taking this campaign to every corner of […]

Read more

January 27, 2021 | Maryam Shahzad

Hogan Urges More Vaccine Production as Biden Announces Short-Term Increase in Doses

President Joe Biden announced Tuesday that overall COVID-19 vaccine allocations to states will increase from about 8.6 million doses to about 10 million beginning next week. The weekly increase will last for three weeks, said the White House. The Washington Post reported that according to senior Biden administration officials, the increase will primarily come from […]

Read more

December 15, 2020 | Maryam Shahzad

State Anticipates Every Hospital Will Get COVID-19 Vaccine Over Next Two Weeks

State officials anticipate that every Maryland hospital will receive COVID-19 vaccine doses over the next two weeks. The FDA approved Pfizer’s vaccine last Friday, and distribution is underway. This week, Adventist HealthCare Shady Grove Medical Center and Adventist Health Care White Oak Medical Center are expected to receive 975 doses each. MedStar Health, which includes […]

Read more

October 21, 2020 | Maryam Shahzad

Maryland Releases Draft COVID-19 Vaccination Plan

Maryland released the initial draft of its COVID-19 vaccination plan. There are currently no coronavirus vaccines approved by the FDA. Referencing CDC information, the draft plan sent to CDC Director Robert Redfield on Oct. 16 said limited vaccine doses could be available by early November, but that is expected to increase considerably in 2021. Patients […]

Read more

August 31, 2020 | Maryam Shahzad

Novavax Reaches Agreement With Canada to Supply COVID-19 Vaccine

Gaithersburg biotechnology company Novavax announced Monday that it has reached an agreement in principle to give Canada up to 76 million doses of Novavax’s COVID-19 vaccine.  In a statement the company said the vaccine is in multiple Phase 2 clinical trials right now. Novavax expects to finalize an agreement that would begin supplying the doses […]

Read more

Engage us on Facebook

Follow us on Twitter